Bayer CropScience FY26 PAT rises 21% to ₹6,892 million

Bayer CropScience Limited reported a 21% increase in Profit After Tax (PAT) to ₹6,892 million for the financial year ended March 31, 2026, driven by disciplined cost management. Revenue from operations rose 3.7% to ₹56,750 million from ₹54,734 million in the previous year. Profit Before Tax (PBT) increased to ₹8,549 million from ₹7,074 million. The company's Board has recommended a final dividend of ₹60 per equity share of ₹10 each, subject to shareholder approval.

Financial Performance

For the quarter ended March 31, 2026 (Q4FY26), the company recorded revenue from operations of ₹11,008 million, compared to ₹10,464 million in the corresponding quarter of the previous year. PBT for the quarter stood at ₹2,064 million, up from ₹1,679 million. PAT for Q4FY26 was ₹1,621 million, compared to ₹1,433 million in the same period last year. Total Comprehensive Income for the year was ₹6,771 million.

Metric	FY 2025-26	Previous Year
Revenue from Operations	₹56,750 million	₹54,734 million
Profit Before Tax	₹8,549 million	₹7,074 million
Profit After Tax	₹6,892 million	₹5,680 million
Q4 Revenue	₹11,008 million	₹10,464 million
Q4 Profit Before Tax	₹2,064 million	₹1,679 million
Q4 Profit After Tax	₹1,621 million	₹1,433 million

Management Commentary

Simon Wiebusch, Vice Chairman & Managing Director and CEO, BCSL, stated that Q4 revenue grew approximately 5%, reflecting the underlying strength of the business despite a softer corn season. Vinit Jindal, Executive Director and Chief Financial Officer, BCSL, noted that PAT growth was supported by disciplined cost and cash flow management and a strong balance sheet. Reserves stood at ₹29,208 million as of March 31, 2026.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+2.56%	+6.01%	-1.17%	+0.62%	-10.04%	-13.11%

Bayer CropScience Limited has notified the stock exchange of an upcoming board meeting scheduled for Tuesday, May 26, 2026, to be conducted through physical/audio-visual means. The intimation has been filed pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was issued on May 11, 2026, and signed by Bharati Shetty, Company Secretary & Compliance Officer (Membership No.: ACS 24199).

Key Agenda Items

The board meeting has been convened to address the following key matters, as outlined in the regulatory filing:

Audited Financial Results: To take on record the audited financial results of the company for the quarter and financial year ended on March 31, 2026.
Final Dividend Consideration: To consider the recommendation of a final dividend for the Financial Year 2025-26, if any.

Meeting Details at a Glance

The following table summarises the key details of the scheduled board meeting:

Parameter:	Details
Meeting Date:	Tuesday, May 26, 2026
Mode:	Physical / Audio-Visual
Financial Period Under Review:	Quarter and Financial Year ended March 31, 2026
Dividend Consideration:	Final Dividend for FY2025-26 (if any)
Regulatory Basis:	Regulation 29, SEBI (LODR) Regulations, 2015
Filing Date:	May 11, 2026

Trading Window Closure

In accordance with the company's Prohibition of Insider Trading Policy, the trading window has been closed for all designated persons of the company. This measure is a standard compliance requirement ahead of the announcement of financial results and any material corporate decisions.

The filing was submitted to the Department of Corporate Services, BSE Limited, at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001. Bayer CropScience Limited is headquartered at Bayer House, Central Avenue, Hiranandani Estate, Thane (West) – 400 607, Maharashtra, India, and carries the CIN: L24210MH1958PLC011173.